HC Wainwright reaffirmed their neutral rating on shares of Tempest Therapeutics (NASDAQ:TPST – Free Report) in a report published on Thursday morning, Marketbeat reports. They currently have a $ ...

As of April 8 at 7:30:25 PM GMT+2. Market Open.

At close: April 8 at 7:30:25 p.m. GMT+2 ...

Roche (RHHBY) announced that the European Commission, EC, has approved Columvi in combination with gemcitabine and oxaliplatin for the ...